Loading chart…
PRE-MARKET
Advanced Enzyme Technologies Limited, together with its subsidiaries, engages in the research, development, manufacture, and marketing of enzymes and probiotics in India, Europe, the United States, Asia, and internationally. The company offers serratiopeptidase, fungal lactase, peptizyme SP, nattokinase, fungal lipase, alpha galactosidase, saccharomyces boulardii, hemicellulose, papain, bromelain, fungal proteases, and bacterial alpha amylase. It also provides probiotics for human and animal nutrition.
Advanced Enzyme Technologies Limited (ADVENZYMES) is listed on the NSE in the Basic Materials sector, Specialty Chemicals industry. The ADVENZYMES share price is ₹284.20 (-0.04% today), with a market capitalisation of ₹31B and a price-to-earnings (P/E) ratio of 18.6. MarketRipple tracks the ADVENZYMES investment thesis, the ripple-chain impact of market events on Advanced Enzyme Technologies Limited, and the Basic Materials sector outlook.
Open
₹280.50
High
₹287.50
Low
₹280.50
Prev. Close
₹284.30
52W High
₹419.00
52W Low
₹246.80
Day range
₹280.50–₹287.50
52-week range
₹246.80–₹419.00
Volume
65K
P/E
18.6
ROE
11.0%
D/E
0.02
Margin
21.9%
Advanced Enzyme Technologies Limited (NSE: ADVENZYMES) is currently trading at ₹284.20 (-0.04%).
Advanced Enzyme Technologies Limited's market capitalization is ₹31B.
Advanced Enzyme Technologies Limited's price-to-earnings (P/E) ratio is 18.6.
Advanced Enzyme Technologies Limited operates in the Basic Materials sector (Specialty Chemicals).
Analyst consensus on Advanced Enzyme Technologies Limited currently reads neutral, based on 1 analyst covering the stock. This is third-party analyst data, not a MarketRipple recommendation.